查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493260

美國體外心臟去顫器市場規模、佔有率和趨勢分析報告：按產品、最終用途、細分市場預測，2024-2030 年

U.S. External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual, Automated, Wearable), By End-use (Hospital, Prehospital, Public Access Market), And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國體外心臟去顫器市場成長與趨勢：

Grand View Research最新報告顯示，到2030年，美國體外心臟去顫器市場規模預計將達到23.3億美元，2024年至2030年複合年成長率為9.0%。

心血管疾病發生率的增加是市場成長的主要驅動力。根據美國美國約有 805,000 人心臟病發作。技術進步促進了創新體外心臟去顫器的發展。此外，美國不斷上漲的醫療保健成本以及對緊急醫療服務和醫療保健基礎設施的投資正在推動醫院、診所、救護車和其他醫療保健設施中產品的採用。

對醫療保健設施投資的增加正在推動對去心房顫動技術的需求。關於心臟麻痹和早期去心房顫動重要性的公眾意識提升宣傳活動，以及有效使用自動體外心臟心臟去顫器(AED) 的培訓計劃，在推動市場成長方面發揮關鍵作用。認知的提高增加了公共設施和私人組織對心臟去顫器的需求。主要企業正在採取各種策略，例如新產品發布、併購和聯盟，以獲取更高的市場佔有率。例如，2023 年 3 月，Safe Life 收購了 Coro Medical 和 AED.us。此次收購將 Safe Life 的救生設備和服務擴展到美國各地。

美國體外心臟去顫器市場報告亮點

  • AED產品細分市場將在2023年佔據市場主導地位，佔整體收益的40%。預計 2024 年至 2030 年該細分市場將以最快的複合年成長率成長。
  • 這是由於心臟去顫器的技術進步、心血管疾病 (CVD) 盛行率的增加以及人們對即時心臟護理重要性的認知的提高。
  • 由於心臟病導致的住院率上升以及心臟去顫器安裝量的增加，醫院最終用途部門在 2023 年佔據最大收益佔有率，超過 25%。
  • 由於人們對早期去心房顫動重要性的認知不斷提高並開展了培訓計劃，預計從 2024 年到 2030 年，公共接入終端使用領域的複合年成長率將達到最快。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國體外心臟去顫器市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國體外心臟去顫器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國體外心臟去顫器市場：產品預估及趨勢分析

  • 2023年及2030年產品市場佔有率
  • 細分儀表板
  • 美國體外心臟去顫器市場：按產品分類的前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 手動的
  • 自動的
  • 穿戴式自動心臟去顫器

第5章美國體外心臟去顫器市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 以最終用途分類的美國體外電擊器市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 院前救護
  • 公共訪問
  • 替代性照料
  • 家庭保健

第6章 競爭狀況

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • Koninklijke Philips NV
    • ZOLL Medical Corporation
    • Stryker
    • Nihon Kohden Corporation
    • Shenzhen Mindray Bio-Medical Electronics
    • Schiller Americas, inc.
    • Medtronic
    • Amiitalia
    • MEDIANA Co., Ltd.
Product Code: GVR-4-68040-267-1

U.S. External Defibrillators Market Growth & Trends:

The U.S. external defibrillators market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of cardiovascular conditions is a major factor contributing to market growth. As per the Centers for Disease Control and Prevention (CDC), every year in the U.S., around 805,000 people have a heart attack. Technological advancements have led to the development of innovative external defibrillators. In addition, the growing healthcare expenditure in the U.S., coupled with investments in emergency medical services and healthcare infrastructure, has supported the product adoption in hospitals, clinics, ambulances, and other healthcare facilities.

This increased investment in healthcare facilities has boosted the demand for advanced defibrillation technologies. Public awareness campaigns about sudden cardiac arrest & the importance of early defibrillation, along with training programs on using automated external defibrillators (AEDs) effectively, have played a crucial role in driving market growth. Increased awareness has led to a higher demand for defibrillators in public settings and private organizations. Key companies undertake various strategies, such as new product launches, M&As, and partnerships, to gain higher market shares. For instance, in March 2023, Safe Life acquired Coro Medical and AED.us. This acquisition helped expand Safe Life's life-saving equipment and services across the U.S.

U.S. External Defibrillators Market Report Highlights:

  • The AED product segment dominated the market in 2023 and around for a share of 40% of the overall revenue. The segment is expected to grow at the fastest CAGR from 2024 to 2030
  • This can be attributed to the technological advancements in defibrillator devices, increasing prevalence of cardiovascular diseases (CVDs), and growing awareness about the importance of immediate cardiac care
  • The hospital end-use segment accounted for the largest revenue share of over 25% in 2023 owing to increased rates of hospital admissions due to heart conditions and increasing defibrillator installations
  • The public access end-use segment is anticipated to witness the fastest CAGR from 2024 to 2030 due to the rising awareness of the importance of early defibrillation and training programs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. External Defibrillators Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidences of cardiac arrest
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing healthcare expenditure
      • 3.2.1.4. Growing awareness and training program
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations & approvals
      • 3.2.2.2. Limited accessibility
  • 3.3. U.S. External Defibrillators Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. External Defibrillators Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. External Defibrillators Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 For The Following
    • 4.4.1. Manual
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Automated
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Wearable Cardioverter Defibrillators
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. External Defibrillators Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. External Defibrillators Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Hospital
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Prehospital
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Public Access Market
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Alternate Care Market
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Home Healthcare
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company heat map analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. Koninklijke Philips N.V.
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. ZOLL Medical Corporation
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Stryker
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Nihon Kohden Corporation
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Shenzhen Mindray Bio-Medical Electronics
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Schiller Americas, inc.
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Medtronic
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Amiitalia
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. MEDIANA Co., Ltd.
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. external defibrillators market, by product, 2018 - 2030 (USD Million)
  • Table 3 U.S. external defibrillators market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. external defibrillators market: market outlook
  • Fig. 9 U.S. external defibrillators competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. external defibrillators market driver impact
  • Fig. 14 U.S. external defibrillators market restraint impact
  • Fig. 15 U.S. external defibrillators market: Product movement analysis
  • Fig. 16 U.S. external defibrillators market: Product outlook and key takeaways
  • Fig. 17 Manual market estimates and forecast, 2018 - 2030
  • Fig. 18 Automated market estimates and forecast, 2018 - 2030
  • Fig. 19 Wearable cardioverter defibrillators market estimates and forecast, 2018 - 2030
  • Fig. 20 U.S. external defibrillators Market: End-use movement Analysis
  • Fig. 21 U.S. external defibrillators market: End-use outlook and key takeaways
  • Fig. 22 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 23 Pre-hospital market estimates and forecasts, 2018 - 2030
  • Fig. 24 Public access market estimates and forecasts, 2018 - 2030
  • Fig. 25 Alternate care market estimates and forecasts, 2018 - 2030
  • Fig. 26 Home healthcare market estimates and forecasts, 2018 - 2030